PET Scan to Map the Areas of the Brain Involved in Planning
NCT ID: NCT00001363
Last Updated: 2008-03-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
230 participants
OBSERVATIONAL
1993-01-31
2001-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
When a region of the brain is active, it uses more fuel in the form of oxygen and sugar (glucose). As the brain uses more fuel it produces more waste products, carbon dioxide and water. Blood carries fuel to the brain and waste products away from the brain. As brain activity increases blood flow to and from the area of activity increases also. Knowing these facts, researchers can use radioactive water (H215O) and PET scans to observe what areas of the brain are receiving more blood flow.
This study will attempt to determine the areas of the brain activated by planning processes and decision making. Researchers will ask patients to participate in tests and games (chess) that will stimulate the areas of the brain involved with decision making and planning while undergoing the water PET blood flow technique.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain Blood Flow Studies of Language and Memory
NCT00001288
PET Scan of Brain Metabolism in Relation to Age and Disease
NCT00001972
Positron Emission Tomography (PET) to Study Brain Signaling
NCT00044200
Magnetic Resonance Imaging Studies of Motor and Thought Processes
NCT00001361
Metabolic Abnormalities in Children With Epilepsy
NCT00001325
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Males and female subjects from two age ranges: 18-30 and 50-65 years of age.
Individuals with a history of neurological or psychiatric disorder will not be included nor will individuals currently taking psychoactive medication.
Patients:
Patients with outstanding problems in planning.
Patients must have a diagnosed CNS disorder with lesion localization verified by MRI scanning available from the referring physician or completed at the NIH Clinical Center.
Patients with unilateral or bilateral lesions that meet the behavioral criteria for selection (planning disorder).
Patients will be medication free (or taking medication with no known central nervous system effects) and be able to understand instructions and task demands.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institute of Neurological Disorders and Stroke (NINDS)
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Nichelli P, Grafman J, Pietrini P, Alway D, Carton JC, Miletich R. Brain activity in chess playing. Nature. 1994 May 19;369(6477):191. doi: 10.1038/369191a0. No abstract available.
Partiot A, Grafman J, Sadato N, Flitman S, Wild K. Brain activation during script event processing. Neuroreport. 1996 Feb 29;7(3):761-6. doi: 10.1097/00001756-199602290-00020.
Flitman S, O'Grady J, Cooper V, Grafman J. PET imaging of maze processing. Neuropsychologia. 1997 Apr;35(4):409-20. doi: 10.1016/s0028-3932(96)00086-3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
93-N-0077
Identifier Type: -
Identifier Source: secondary_id
930077
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.